DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Pujade-Lauraine E.
Avelumab alone or in combination with pegylated liposomal doxorubicin (PLD) vs. PLD alone in platinum-resistant or refractory epithelial ovarian cancer: primary and biomarker analysis of the phase 3 trial. SO Meeting 2019.
Gynecol Oncol 2019;
154 (Suppl. 01) 21-22
DOI: 10.1016/j.ygyno.2019.04.053.
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.